Purchase Order W81K0018P0099
- Not listed
- This is a $121,580.00 Firm Fixed Price Purchase Order contract awarded by the Department of the Army Medical Command to Vericel Corporation, a manufacturer of advanced therapy products for sports medicine and severe burn care. The contract is for the supply of CULTURED EPICEL-CEA, which are surgical implants containing cultured chondrocytes used to aid tissue repair procedures. The contract has a completion date of August 31, 2017 and does not have a set-aside designation. Through this and other...
- This is a $127,809 firm fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The contract is for the supply of EPICEL-CEA skin grafts, which are advanced cell therapy products used in orthopedic and reconstructive medical procedures. Vericel specializes in developing innovative cell and tissue-based therapies, and this contract supports the...
- The Department of the Army Medical Command awarded a Firm Fixed Price Purchase Order contract to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, to provide Epicel (Cultured Epidermal Autografts) grafts for a patient-specific surgery. The $169,149.00 contract was awarded on May 22, 2018, with a completion date of June 14, 2018. The contract did not have a set-aside designation. Vericel Corporation is an experienced federal contractor, having been awarded over...
- The Department of the Army Medical Command awarded a Firm Fixed Price Purchase Order contract to Vericel Corporation, a for-profit manufacturer of medical goods, to provide Cultured EPICEL-CEA skin grafts. The contract has a potential value of $228,275.00 and a completion date of January 3, 2019. The contract was awarded on December 31, 2018 without a set-aside designation. Vericel Corporation is a leader in advanced cell therapies for the sports medicine and severe burn care markets, and has...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products for sports medicine and severe burn care. The $56,171 contract is for the delivery of surgical implants, membranes, and other biological products to support healthcare services for veterans at VA facilities. The contract has a completion date of May 29, 2024 and was awarded on March...
- This federal contract award, valued at $56,171.00, was issued by the Veterans Integrated Service Network 12 (VISN 12), which is part of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, primarily for the supply of the company's MACI cultured chondrocyte implant and other surgical implants, membranes, and biological products. The contract is a firm fixed price purchase order with a completion...
- Vericel Corporation, a Cambridge, Massachusetts-based medical technology company specializing in advanced cell therapy and tissue engineering, has been awarded a firm fixed-price purchase order valued at $69,772 by the Department of Veterans Affairs through Veterans Integrated Service Network 6. The award, issued on January 20, 2026, with an ultimate completion date of January 27, 2026, represents a direct procurement with no set-aside designation. Based on Vericel's established contract history...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The $52,252 contract is for the delivery of surgical implants, with a period of performance ending on November 22, 2023. Vericel Corporation is a registered federal contractor that has secured over 50 contracts with the VA and the Defense Health Agency since 2015, primarily to provide specialized medical...
- This $52,252 firm fixed price purchase order was awarded by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The contract is for the supply of MACI, a cultured chondrocyte implant used for cartilage repair procedures, as well as other surgical implants, membranes, and biological products to support healthcare services for veterans and military personnel. Vericel has secured numerous federal contracts with the VA and...
- This federal contract award, valued at $56,171.00, was made by the U.S. Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The contract is for the provision of IMPLANT, a surgical implant product, with an ultimate completion date of August 16, 2024. This contract was not set aside for a specific business type. Vericel Corporation, a long-standing federal contractor since 2015, has secured numerous contracts with the VA and the...
This is a $97,050.00 firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The contract is for the provision of Cultured Epicel-CEA, which are advanced cell therapy products used in orthopedic and reconstructive medical procedures. The contract has no set-aside designation, indicating it was competed on the open market. Vericel Corporation is a regular recipient of similar federal contract awards from the Department of Veterans Affairs (VA) and the Defense Health Agency, demonstrating the company's critical role in supplying specialized medical technologies to support healthcare services for veterans and military personnel.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Award Sole Source | 0011129554 | Department of the Army Medical Command | Award Notice 1/1 | 1/4/18, 11:46 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.1k | 1/4/18 |